Business Context and Reporting Period
This Form 8-K filing by Inogen, Inc. (Delaware) covers events occurring on August 6, 2014, with the report dated August 7, 2014. The filing addresses changes to the Board of Directors and related compensatory arrangements.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on corporate governance changes.
Material Changes
- Resignation: Charles E. Larsen resigned as a member of the Board of Directors and the Audit Committee, effective immediately on August 6, 2014. The resignation was not due to any disagreement with the Company regarding operations, policies, or practices.
- Appointment: Benjamin Anderson-Ray, a current director, was appointed to replace Mr. Larsen on the Audit Committee.
- Election: Heather D. Rider was elected to the Board of Directors as a Class I director, effective immediately. Her term expires at the 2015 annual meeting of stockholders.
- Committee Assignment: Ms. Rider was appointed to the Compensation, Nominating and Governance Committee, replacing Benjamin Anderson-Ray.
Guidance, Outlook, and Compensation Details
The filing details the compensatory arrangements for the newly elected director, Heather D. Rider:
- Initial Option Grant: Ms. Rider was granted a non-statutory option to purchase 2,222 shares of common stock. The exercise price equals the closing price on the grant date. Vesting occurs in 24 equal monthly installments.
- Annual Retainer: Ms. Rider will receive a base annual retainer of $35,000, payable quarterly in arrears on a pro-rata basis.
- Future Grants: The Company expects to grant an option to purchase 6,666 shares of common stock on the date of each annual meeting of stockholders, subject to continued service. These annual grants vest in 12 monthly installments or fully on the next annual meeting date.
- Expenses and Indemnification: The Company will reimburse reasonable expenses, and Ms. Rider has executed a standard indemnification agreement.
No financial guidance, outlook, or discussion of risks and contingencies is provided in this specific filing.
Key Facts for Investor Verification
- Verify the impact of the Board composition change on the Audit Committee and Compensation Committee dynamics.
- Confirm the total equity dilution from the initial 2,222-share option grant and future annual grants of 6,666 shares.
- Review Ms. Rider's background in human resources at Cymer, Alphatec Holdings, and Intuitive Surgical to assess her fit for the Board.
- Note that the resignation of Charles E. Larsen was explicitly stated as not being related to any disagreement with the Company.